Patients with interferon expressing oral pathologies are susceptible to COVID-19 infection.

ABSTRACT:

SUBMITTER: Sarode GS 

PROVIDER: S-EPMC7422813 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature